FUNDING OPPORTUNITIES

Check out these grants and other funding opportunities. Learn more »


Grant Opportunity Announcement - June 2021

The Indiana Department of Health’s (IDOH’s) Division of Trauma and Injury Prevention has been awarded a grant from the Centers for Disease Control and Prevention (CDC) to increase comprehensiveness and timeliness of drug overdose surveillance data; make the Prescription Drug Monitoring Program more user-friendly; work with health systems, insurers, and communities to improve opioid prescribing; and build state and local capacity for public health programs related to substance use disorder. As part of these efforts, the Indiana Department of Health is implementing the Indiana Communities Advancing Recovery Efforts (IN CAREs) Enhancing Community Healthcare Outcomes (ECHO). Learn more »


Provisional Drug Overdose Death Counts

This week, the Centers for Disease Control and Prevention (CDC) released data showing an unprecedented 93,331 predicted drug overdose deaths in 2020. It is likely that the COVID-19 pandemic exacerbated the overdose epidemic, but we know that overdose numbers were rising even before the pandemic hit. This is why the Biden-Harris Administration is working urgently to take actions that treat substance use disorder as a chronic—not acute—condition that requires long-term investments and strategies. Learn more »


a

Indiana Pregnancy Promise Program

The Indiana Pregnancy Promise Program is a free, voluntary program for pregnant Medicaid members who use opioids or have used opioids in the past. The program ensures individuals’ privacy and confidentiality. The Pregnancy Promise Program connects individuals to prenatal and postpartum care, other physical and mental health care, and treatment for opioid use disorder. Learn more »   PPP Member Handout (English)   PPP Member Handout (Spanish)


Amid the state's successes in addressing addiction, 1 failure stands out

Two steps forward. In Indiana in 2017 several impactful things happened regarding addiction, now more commonly referred to as "substance use disorder." Learn more »


Fentanyl Test Strips Fact Sheet

"Drug checking" is a form of harm reduction in which illicit drugs or illegally obtained prescription pills are chemically analyzed to determine the composition of the substance or the presence of an adulterant. One form of drug checking is the distribution and use of fentanyl test strips (FTS), which are disposable, single-use tests that can detect the presence of fentanyl or fentanyl analogs in a substance. Learn more »


Federal Grantees May Now Use Funds to Purchase Fentanyl Test Strips

The Centers for Disease Control and Prevention (CDC) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced today that federal funding may now be used to purchase rapid fentanyl test strips (FTS) in an effort to help curb the dramatic spike in drug overdose deaths largely driven by the use of strong synthetic opioids, including illicitly manufactured fentanyl. Learn more »


The Biden-Harris Administration's Statement of Drug Policy Priorities for Year One

President Biden has made clear that addressing the overdose and addiction epidemic is an urgent priority for his administration. In March, the President signed into law the American Rescue Plan, which appropriated nearly $4 billion to enable the Substance Abuse and Mental Health Services Administration and the Health Resources and Services Administration to expand access to vital behavioral health services. President Biden has also said that people should not be incarcerated for drug use but should be offered treatment instead. The President has also emphasized the need to eradicate racial, gender, and economic inequities that currently exist in the criminal justice system. Learn more »


Gov. Holcomb announces initiative to place overdose reversal kits in all 92 counties

Governor Eric J. Holcomb and the Indiana Family and Social Services Administration's Division of Mental Health and Addiction today announced the state will partner with Overdose Lifeline, Inc. to expand access to the opioid reversal agent naloxone through the purchase of 24/7-access "NaloxBox" units. Learn more »